STRS Ohio’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-45,000
Closed -$1.07M 2126
2019
Q4
$1.07M Sell
45,000
-2,000
-4% -$55.2K ﹤0.01% 869
2019
Q3
$1.26M Buy
47,000
+2,000
+4% +$56.1K 0.01% 737
2019
Q2
$1.22M Sell
45,000
-600
-1% -$18.8K 0.01% 763
2019
Q1
$1.58M Buy
45,600
+600
+1% +$17.3K 0.01% 699
2018
Q4
$878K Hold
45,000
﹤0.01% 837
2018
Q3
$1.2M Sell
45,000
-3,500
-7% -$114K 0.01% 798
2018
Q2
$1.83M Sell
48,500
-11,500
-19% -$440K 0.01% 667
2018
Q1
$1.96M Sell
60,000
-136,169
-69% -$5.98M 0.01% 628
2017
Q4
$9.55M Sell
196,169
-10,931
-5% -$553K 0.04% 366
2017
Q3
$11.2M Buy
207,100
+24,600
+13% +$1.44M 0.05% 349
2017
Q2
$10.3M Sell
182,500
-8,600
-5% -$344K 0.05% 363
2017
Q1
$7.49M Buy
191,100
+300
+0.2% +$9.55K 0.03% 429
2016
Q4
$4.28M Sell
190,800
-4,200
-2% -$82K 0.02% 539
2016
Q3
$4.43M Buy
+195,000
New +$4.58M 0.02% 519
2016
Q1
Sell
-4,800
Closed -$152K 1950
2015
Q4
$246K Buy
4,800
+2,300
+92% +$112K ﹤0.01% 1484
2015
Q3
$106K Buy
2,500
+700
+39% +$33.8K ﹤0.01% 1653
2015
Q2
$81K Buy
+1,800
New +$72.4K ﹤0.01% 1708
2013
Q3
Sell
-4,500
Closed -$107K 1945
2013
Q2
$111K Buy
+4,500
New +$89.4K ﹤0.01% 1612

Other funds holding PTLA

STRS Ohio's PTLA Position: Q1 2020 in Review

STRS Ohio sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 45,000 shares — an estimated $1.07M sold.

STRS Ohio first reported a position in PTLA in Q2 2013 and held it in 18 quarters. The position peaked at $11.2M in Q3 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • STRS Ohio reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • STRS Ohio sold 45,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1.07M.
  • STRS Ohio first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • STRS Ohio's Portola Pharmaceuticals, Inc. position peaked at $11.2M in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on STRS Ohio's 13F filing for Q1 2020, filed 23 Apr 2020.